Related Experiment Video
Updated: Sep 11, 2026
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Chloramphenicol binding to normal and kwashiorkor sera
Abstract:
The binding of chloramphenicol to normal and kwashiorkor sera was investigated in vitro. Chloramphenicol is predominantly albumin bound, although a significant degree of binding to the other major protein fractions occurs. From the clinical view point, a decreased degree of binding of kwashiorkor serum (+/-5%) is not of significance.
Insights
This study investigated chloramphenicol binding in normal and kwashiorkor sera. While binding differs slightly in kwashiorkor serum, it is not clinically significant for drug efficacy.
Area of Science:
- Pharmacology
- Clinical Chemistry
- Biochemistry
Background:
- Kwashiorkor is a severe form of malnutrition.
- Drug binding to serum proteins can affect efficacy.
- Understanding chloramphenicol binding is crucial for its therapeutic use.
Purpose of the Study:
- To investigate the in vitro binding of chloramphenicol to normal and kwashiorkor sera.
- To determine the clinical significance of altered protein binding in kwashiorkor.
Main Methods:
- In vitro investigation of chloramphenicol binding.
- Analysis of binding to major protein fractions in sera.
Main Results:
- Chloramphenicol predominantly binds to albumin in both normal and kwashiorkor sera.
- Significant binding also occurs with other major protein fractions.
- A slight decrease in binding (around 5%) was observed in kwashiorkor serum.
Conclusions:
- The predominant binding of chloramphenicol to albumin is consistent across normal and kwashiorkor sera.
- The minor reduction in binding observed in kwashiorkor serum does not hold clinical significance.
- Therapeutic drug monitoring for chloramphenicol may not require adjustment based on kwashiorkor-related binding changes.
